Annual Working Capital
$40.66 M
-$15.26 M-27.29%
December 31, 2023
Summary
- As of February 7, 2025, LTRN annual working capital is $40.66 million, with the most recent change of -$15.26 million (-27.29%) on December 31, 2023.
- During the last 3 years, LTRN annual working capital has risen by +$20.98 million (+106.57%).
- LTRN annual working capital is now -42.23% below its all-time high of $70.39 million, reached on December 31, 2021.
Performance
LTRN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$26.32 M
-$4.37 M-14.24%
September 30, 2024
Summary
- As of February 7, 2025, LTRN quarterly working capital is $26.32 million, with the most recent change of -$4.37 million (-14.24%) on September 30, 2024.
- Over the past year, LTRN quarterly working capital has dropped by -$18.85 million (-41.73%).
- LTRN quarterly working capital is now -67.83% below its all-time high of $81.82 million, reached on March 31, 2021.
Performance
LTRN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
LTRN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.3% | -41.7% |
| 3 y3 years | +106.6% | -64.7% |
| 5 y5 years | +10000.0% | - |
LTRN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.2% | at low | -62.6% | at low |
| 5 y | 5-year | -42.2% | +5369.1% | -67.8% | +9835.8% |
| alltime | all time | -42.2% | >+9999.0% | -67.8% | +9835.8% |
Lantern Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.32 M(-14.2%) |
| Jun 2024 | - | $30.69 M(-13.6%) |
| Mar 2024 | - | $35.52 M(-12.7%) |
| Dec 2023 | $40.66 M(-27.3%) | $40.66 M(-10.0%) |
| Sep 2023 | - | $45.17 M(-5.9%) |
| Jun 2023 | - | $48.03 M(-8.3%) |
| Mar 2023 | - | $52.37 M(-6.3%) |
| Dec 2022 | $55.92 M | $55.92 M(-5.0%) |
| Sep 2022 | - | $58.88 M(-2.4%) |
| Jun 2022 | - | $60.36 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $64.59 M(-8.2%) |
| Dec 2021 | $70.39 M(+257.6%) | $70.39 M(-5.6%) |
| Sep 2021 | - | $74.55 M(-6.2%) |
| Jun 2021 | - | $79.44 M(-2.9%) |
| Mar 2021 | - | $81.82 M(+315.7%) |
| Dec 2020 | $19.68 M(+2547.6%) | $19.68 M(-9.1%) |
| Sep 2020 | - | $21.66 M(-7.1%) |
| Jun 2020 | - | $23.32 M(+8703.7%) |
| Mar 2020 | - | $264.90 K(-64.4%) |
| Dec 2019 | $743.50 K(-460.2%) | $743.50 K |
| Dec 2018 | -$206.40 K | - |
FAQ
- What is Lantern Pharma annual working capital?
- What is the all time high annual working capital for Lantern Pharma?
- What is Lantern Pharma annual working capital year-on-year change?
- What is Lantern Pharma quarterly working capital?
- What is the all time high quarterly working capital for Lantern Pharma?
- What is Lantern Pharma quarterly working capital year-on-year change?
What is Lantern Pharma annual working capital?
The current annual working capital of LTRN is $40.66 M
What is the all time high annual working capital for Lantern Pharma?
Lantern Pharma all-time high annual working capital is $70.39 M
What is Lantern Pharma annual working capital year-on-year change?
Over the past year, LTRN annual working capital has changed by -$15.26 M (-27.29%)
What is Lantern Pharma quarterly working capital?
The current quarterly working capital of LTRN is $26.32 M
What is the all time high quarterly working capital for Lantern Pharma?
Lantern Pharma all-time high quarterly working capital is $81.82 M
What is Lantern Pharma quarterly working capital year-on-year change?
Over the past year, LTRN quarterly working capital has changed by -$18.85 M (-41.73%)